04/23/2025
4:28 PM | Allogene Therapeutics (Issuer)
Yoshiyama Annie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
3:49 PM | Allogene Therapeutics (Subject)
Yoshiyama Annie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2025
8:35 AM | Allogene Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
03/18/2025
4:28 PM | Allogene Therapeutics (Issuer)
Beneski Benjamin Machinas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:30 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
9:01 AM | Allogene Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
03/05/2025
3:11 PM | Allogene Therapeutics (Issuer)
Beneski Benjamin Machinas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
8:58 PM | Allogene Therapeutics (Issuer)
Beneski Benjamin Machinas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2025
8:02 AM | Allogene Therapeutics (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SCHEDULE 13G | |
02/05/2025
3:16 PM | Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:32 PM | Allogene Therapeutics (Subject)
Roberts Zachary (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for ALLO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Allogene Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/03/2025
3:28 PM | Allogene Therapeutics (Subject)
Parker Geoffrey M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
7:35 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2025
7:10 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:11 PM | Allogene Therapeutics (Issuer)
Belldegrun Arie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:13 PM | Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:14 PM | Allogene Therapeutics (Issuer)
Yoshiyama Annie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:15 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:16 PM | Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:30 PM | Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:22 PM | Allogene Therapeutics (Subject)
Roberts Zachary (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
3:53 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
1:15 PM | Allogene Therapeutics (Subject)
Humer Franz B (Reporting)
| Form 144/A | |
12/02/2024
1:11 PM | Allogene Therapeutics (Subject)
Humer Franz B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
9:57 AM | Allogene Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
10/23/2024
3:21 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
2:24 PM | Allogene Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G/A | |
06/20/2024
3:31 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:33 PM | Allogene Therapeutics (Subject)
MESSEMER DEBORAH M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:30 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
4:28 PM | Allogene Therapeutics (Issuer)
Kazam Joshua A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:29 PM | Allogene Therapeutics (Issuer)
WITTE OWEN N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:30 PM | Allogene Therapeutics (Issuer)
Humer Franz B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:33 PM | Allogene Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:34 PM | Allogene Therapeutics (Issuer)
Barrett Elizabeth A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:35 PM | Allogene Therapeutics (Issuer)
Mayo Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:25 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:09 PM | Allogene Therapeutics (Issuer)
Humer Franz B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
1:08 PM | Allogene Therapeutics (Subject)
Humer Franz B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
8:33 PM | Allogene Therapeutics (Issuer)
Belldegrun Arie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:01 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the May 1st funding window clos |
05/20/2024
5:02 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:38 PM | Allogene Therapeutics (Filer)
| Form 424B5 | |
05/14/2024
3:40 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:02 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy ALLO Stock Free ALLO Stock Alerts